TABLE 1.
Parameters Laboratory |
Basal | ECCO2R | 24 h post ECCO2R | |||
---|---|---|---|---|---|---|
24 h | 7 days | 14 days | 27 days | |||
Hemoglobin (gr/L) | 119 | 75 | 81 | 76 | 68 | 8,2 |
Leukocytes (109/L) | 8.8 | 13.7 | 15.2 | 14.2 | 16.3 | 13870 |
Platelets (109/L) | 398 | 321 | 176 | 166 | 393 | 408000 |
CRP (nmol/L) | 722.8 | 761.9 | 1160 | 1583 | 393.3 | 310.4 |
Ureic nitrogen (mmol/L) | 5.0 | 5.7 | 7.0 | 6.4 | 21.5 | 55 |
Creatinine (umol/L) | 53.0 | 23.5 | 23.5 | 35.36 | 79.5 | 0.97 |
Sodium (mmol/L) | 133.0 | 136.4 | 134.0 | 141.0 | 143.0 | 141 |
Potassium (mmol/L) | 4.3 | 4.8 | 4.7 | 3.7 | 4.6 | 4.8 |
Ventilatories |
3.0 |
2.5 |
2.5 |
3.0 |
4.0 |
4.0 |
Vt (ml/kg ideal) | ||||||
RR (breaths/min) | 60 | 24 | 26 | 24 | 30 | 30 |
PEEP (cmH2O) | 4 | 4 | 4 | 4 | 4 | 4 |
Plateau pressure (cmH2O) | 18 | 18 | 19 | 19 | 18 | 18 |
Distension pressure (cmH2O) | 13 | 14 | 15 | 15 | 14 | 14 |
Compliance (ml/cmH2O) | 16 | 16 | 15 | 15 | 16 | 16 |
PaO2/FiO2 | 81.4 | 157.4 | 178.2 | 207.1 | 233.0 | 234.2 |
Blood gases |
7.21 |
7.37 |
7.37 |
7.40 |
7.40 |
7.39 |
pH | ||||||
PaO2 (mmHg) | 94.4 | 78,7 | 77.0 | 93.2 | 94.3 | 82.0 |
PaCO2 (mmHg) | 96.8 | 54.4 | 50.7 | 49.4 | 42.0 | 45.0 |
Bicarbonate (mmol/L) | 37.5 | 30.9 | 29.2 | 30.2 | 25.7 | 26.7 |
Lactate (mmol/L) | 0.7 | 0.6 | 0.7 | ‐ | ‐ | ‐ |
ECCO2R |
500 |
400 |
300 |
320 |
400 |
‐ |
Blood flow (ml/min) | ||||||
Oxygen flow (L/min) | 7 | 7 | 7 | 6 | 4 | ‐ |
CO2 removal (ml/min) | ‐ | ‐ | 61 | 57 | ‐ | ‐ |
Hemodynamics |
89 |
77 |
78 |
124 |
74 |
91 |
Mean arterial pressure (mmHg) | ||||||
HR (heartbeat/min) | 88 | 106 | 119 | 83 | 101 | 98 |
Norepinephrine dose (ug/kg/min) | 0.01 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 |
Abbreviations: CRP, C‐reactive protein; ECCO2R, extracorporeal CO2 removal; FiO2, inspired oxygen fraction; HR, heart rate; PaCO2, partial pressure of carbon dioxide; PaO2, partial pressure of oxygen; PEEP, positive end‐expiratory pressure; RR, respiratory rate; TV: tidal volume.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.